Mashima, T., Iwasaki, R., Kawata, N., Kawakami, R., Kumagai, K., Migita, T., . . . Seimiya, H. (2019). In silico chemical screening identifies epidermal growth factor receptor as a therapeutic target of drug-tolerant CD44v9-positive gastric cancer cells. Br J Cancer.
Citação norma ChicagoMashima, Tetsuo, Risa Iwasaki, Naomi Kawata, Ryuhei Kawakami, Koshi Kumagai, Toshiro Migita, Takeshi Sano, Kensei Yamaguchi, and Hiroyuki Seimiya. "In Silico Chemical Screening Identifies Epidermal Growth Factor Receptor As a Therapeutic Target of Drug-tolerant CD44v9-positive Gastric Cancer Cells." Br J Cancer 2019.
MLA引文Mashima, Tetsuo, et al. "In Silico Chemical Screening Identifies Epidermal Growth Factor Receptor As a Therapeutic Target of Drug-tolerant CD44v9-positive Gastric Cancer Cells." Br J Cancer 2019.